Kimball Electronics Inc
NASDAQ:KE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.91
33.13
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Kimball Electronics Inc
Kimball Electronics, Inc. engages in the provision of engineering, manufacturing and supply of chain services to customers in the automotive, medical, industrial and public safety end markets. The company is headquartered in Jasper, Indiana and currently employs 6,400 full-time employees. The company went IPO on 2014-10-20. The firm provide contract electronics manufacturing services (EMS) and diversified manufacturing services, including engineering and supply chain support to customers in the automotive, medical, industrial and public safety end markets. The firm offers durable electronics. Its diversified contract manufacturing services includes non-electronic components, medical disposables, precision molded plastics, and production automation, test and inspection equipment. Its manufacturing services, including engineering and supply chain support, utilize common production and support capabilities globally. has business units located in the United States, China, Mexico, Poland, Romania, and Thailand, and each of these business units qualify as operating segments. In addition, the Company’s subsidiary, GES Holdings, Inc. has operations located in the United States, China, India, Japan, and Vietnam.
Kimball Electronics, Inc. engages in the provision of engineering, manufacturing and supply of chain services to customers in the automotive, medical, industrial and public safety end markets. The company is headquartered in Jasper, Indiana and currently employs 6,400 full-time employees. The company went IPO on 2014-10-20. The firm provide contract electronics manufacturing services (EMS) and diversified manufacturing services, including engineering and supply chain support to customers in the automotive, medical, industrial and public safety end markets. The firm offers durable electronics. Its diversified contract manufacturing services includes non-electronic components, medical disposables, precision molded plastics, and production automation, test and inspection equipment. Its manufacturing services, including engineering and supply chain support, utilize common production and support capabilities globally. has business units located in the United States, China, Mexico, Poland, Romania, and Thailand, and each of these business units qualify as operating segments. In addition, the Company’s subsidiary, GES Holdings, Inc. has operations located in the United States, China, India, Japan, and Vietnam.
Sales: Net sales for Q1 were $365.6 million, down 2% year-over-year but in line with expectations.
Margins: Gross margin improved to 7.9%, up 160 basis points from last year, driven by product mix, cost cuts, and the closure of the Tampa facility.
Medical Growth: The medical segment grew 13% year-over-year and is expected to remain a key driver for future growth.
Guidance: Fiscal 2026 guidance was reiterated, with net sales expected between $1.35 and $1.45 billion and adjusted operating income at 4–4.25% of sales.
Cash & Debt: Positive cash flow was reported for the seventh straight quarter, and debt reached its lowest level in over three years.
Inorganic Strategy: The company continues to look for tuck-in acquisitions in the medical CMO space but remains financially disciplined.
Outlook: Management expects FY '26 to be the strongest quarter for adjusted operating income, with a return to profitable growth anticipated in FY '27.
